NO20042449L - Injeksjonslosning omfattende en LHRH-antagonist - Google Patents

Injeksjonslosning omfattende en LHRH-antagonist

Info

Publication number
NO20042449L
NO20042449L NO20042449A NO20042449A NO20042449L NO 20042449 L NO20042449 L NO 20042449L NO 20042449 A NO20042449 A NO 20042449A NO 20042449 A NO20042449 A NO 20042449A NO 20042449 L NO20042449 L NO 20042449L
Authority
NO
Norway
Prior art keywords
injection solution
lhrh antagonist
lhrh
antagonist
injection
Prior art date
Application number
NO20042449A
Other languages
English (en)
Other versions
NO333364B1 (no
Inventor
Juergen Engel
Horst Bauer
Werner Sarlikiotis
Matthias Rischer
Frank Guethlein
Dominique Di Stefano
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of NO20042449L publication Critical patent/NO20042449L/no
Publication of NO333364B1 publication Critical patent/NO333364B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20042449A 2001-11-26 2004-06-11 Vandig injeksjonslosning omfattende en LHRH-antagonist samt en fremgangsmate for fremstilling NO333364B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10157628A DE10157628A1 (de) 2001-11-26 2001-11-26 Injektionslösung eines LHRH-Antagonisten
PCT/EP2002/012798 WO2003045419A1 (de) 2001-11-26 2002-11-15 Injektionslösung eines lhrh-antagonisten

Publications (2)

Publication Number Publication Date
NO20042449L true NO20042449L (no) 2004-06-11
NO333364B1 NO333364B1 (no) 2013-05-13

Family

ID=7706799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042449A NO333364B1 (no) 2001-11-26 2004-06-11 Vandig injeksjonslosning omfattende en LHRH-antagonist samt en fremgangsmate for fremstilling

Country Status (33)

Country Link
EP (1) EP1448221B1 (no)
JP (1) JP4343693B2 (no)
KR (1) KR100936636B1 (no)
CN (1) CN100404068C (no)
AR (1) AR037424A1 (no)
AT (1) ATE350050T1 (no)
AU (1) AU2002365504B2 (no)
BR (1) BRPI0214412B8 (no)
CO (1) CO5580793A2 (no)
CY (1) CY1106401T1 (no)
DE (2) DE10157628A1 (no)
DK (1) DK1448221T3 (no)
EA (1) EA010787B1 (no)
ES (1) ES2276970T3 (no)
GE (1) GEP20063861B (no)
HK (1) HK1073078A1 (no)
HR (1) HRP20040587B1 (no)
HU (1) HU230992B1 (no)
IL (2) IL161894A0 (no)
IS (1) IS2725B (no)
ME (1) ME00499B (no)
MX (1) MXPA04005018A (no)
NO (1) NO333364B1 (no)
NZ (1) NZ533712A (no)
PL (1) PL206199B1 (no)
PT (1) PT1448221E (no)
RS (1) RS51408B (no)
RU (1) RU2322969C2 (no)
SI (1) SI1448221T1 (no)
TW (1) TWI312283B (no)
UA (1) UA81612C2 (no)
WO (1) WO2003045419A1 (no)
ZA (1) ZA200404051B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7704977B2 (en) 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
JP2011519928A (ja) * 2008-05-07 2011-07-14 メリオン・リサーチ・Ｉｉｉ・リミテッド ペプチドの組成物及びその調製方法
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
AU2012204213A1 (en) 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
CN103690560B (zh) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 一种转化糖电解质注射液药物组合物及其制备方法
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating
RU2614234C2 (ru) * 2015-03-31 2017-03-23 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства
US20200000872A1 (en) * 2017-01-30 2020-01-02 Antev Limited A composition comprising at least one gnrh antagonist
PL3811927T3 (pl) 2019-10-24 2022-02-07 Sun Pharmaceutical Industries Ltd Trwała pozajelitowa postać dawkowania octanu cetroreliksu

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
NZ534836A (en) * 1999-09-23 2007-07-27 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung

Also Published As

Publication number Publication date
NZ533712A (en) 2006-01-27
MXPA04005018A (es) 2004-08-11
SI1448221T1 (sl) 2007-06-30
CY1106401T1 (el) 2011-10-12
CN1592630A (zh) 2005-03-09
HU230992B1 (hu) 2019-08-28
HUP0401986A2 (hu) 2005-01-28
HK1073078A1 (en) 2005-09-23
RS44904A (en) 2006-10-27
HRP20040587A2 (en) 2004-10-31
ATE350050T1 (de) 2007-01-15
TWI312283B (en) 2009-07-21
RS51408B (sr) 2011-02-28
ME00499B (me) 2011-10-10
IL161894A0 (en) 2005-11-20
BR0214412A (pt) 2004-09-14
IL161894A (en) 2014-05-28
JP2005510544A (ja) 2005-04-21
ZA200404051B (en) 2005-05-25
IS7251A (is) 2004-05-06
JP4343693B2 (ja) 2009-10-14
EP1448221A1 (de) 2004-08-25
TW200300352A (en) 2003-06-01
PL206199B1 (pl) 2010-07-30
RU2322969C2 (ru) 2008-04-27
DE10157628A1 (de) 2003-06-12
ES2276970T3 (es) 2007-07-01
WO2003045419A1 (de) 2003-06-05
EA010787B1 (ru) 2008-10-30
KR20040058312A (ko) 2004-07-03
BRPI0214412B1 (pt) 2016-01-05
HRP20040587B1 (en) 2008-01-31
BRPI0214412B8 (pt) 2021-05-25
DE50209193D1 (de) 2007-02-15
PT1448221E (pt) 2007-03-30
CN100404068C (zh) 2008-07-23
DK1448221T3 (da) 2007-03-19
HUP0401986A3 (en) 2012-09-28
GEP20063861B (en) 2006-06-26
KR100936636B1 (ko) 2010-01-14
UA81612C2 (ru) 2008-01-25
IS2725B (is) 2011-03-15
CO5580793A2 (es) 2005-11-30
RU2004119821A (ru) 2005-04-20
EA200400742A1 (ru) 2004-12-30
NO333364B1 (no) 2013-05-13
AR037424A1 (es) 2004-11-10
AU2002365504A1 (en) 2003-06-10
PL369548A1 (en) 2005-05-02
AU2002365504B2 (en) 2007-06-28
EP1448221B1 (de) 2007-01-03

Similar Documents

Publication Publication Date Title
DE60222245D1 (de) Spritzvorrichtung
DE60112678D1 (de) Direkteinspritzender ottomotor
DE50213435D1 (de) Brennstoffeinspritzventil-zündkerze-kombination
DE50212586D1 (de) Brennstoffeinspritzventil-zündkerze-kombination
DK1383560T4 (da) Infusionssæt
DE60232771D1 (de) Kraftstoffeinspritzeinrichtung
HK1073078A1 (en) Injection solution comprising an lhrh antagonist
DE50112588D1 (de) Einspritzdüse
DE50211785D1 (de) Brennstoffeinspritzsystem
DE50214553D1 (de) Brennstoffeinspritzsystem
DE50209245D1 (de) Neuroprotektives medikament
DK1372771T3 (da) Injektionsordning
DE50203953D1 (de) Kraftstoffeinspritzeinrichtung
DE50212423D1 (de) Kraftstoffeinspritzeinrichtung
DE50208012D1 (de) Kraftstoffeinspritzeinrichtung
DE50206023D1 (de) Brennstoffeinspritzanlage
DE50107401D1 (de) Einspritzdüse
DE10196460T1 (de) Selbstzerstör-Spritze
DE50103958D1 (de) Einspritzsystem
DE50210240D1 (de) Brennstoffeinspritzsystem
DE60223796D1 (de) Nadelanordnung
FR2811378B1 (fr) Injecteur
DE10111783B4 (de) Einspritzdüse
DE50209869D1 (de) Kraftstoffeinspritzeinrichtung
DE50112538D1 (de) Einspritzanlage

Legal Events

Date Code Title Description
MK1K Patent expired